Business Context and Reporting Period
This Form 8-K is a current report filed by Nephros, Inc. on January 30, 2023, regarding corporate governance changes. The report details the resignation of a director and the subsequent appointment of a new committee member.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
- Director Resignation: Thomas Gwydir resigned from the Board of Directors, effective February 1, 2023.
- Reason for Departure: The resignation was not the result of any disagreement with the Company regarding operations, policies, or practices.
- Board Appointment: On February 2, 2023, the Board appointed Alisa Lask to the Audit Committee to fill the vacancy left by Mr. Gwydir.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, future outlook, management commentary on operations, or specific risk factors beyond the standard disclosure of the director's departure.
Key Facts for Investor Verification
- Confirm the effective date of Thomas Gwydir's resignation (February 1, 2023).
- Verify the appointment of Alisa Lask to the Audit Committee (February 2, 2023).
- Note that the departure was explicitly stated as not being due to any disagreement with the Company.